{
  "id": [
    "26429877"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "26429877"
  ],
  "pmcid": [
    "PMC4741766"
  ],
  "doi": [
    "10.18632/oncotarget.5396"
  ],
  "title": [
    "Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma."
  ],
  "authorString": [
    "Rao CV, Janakiram NB, Madka V, Devarkonda V, Brewer M, Biddick L, Lightfoot S, Steele VE, Mohammed A."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Rao CV"
          ],
          "firstName": [
            "Chinthalapally V"
          ],
          "lastName": [
            "Rao"
          ],
          "initials": [
            "CV"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        },
        {
          "fullName": [
            "Janakiram NB"
          ],
          "firstName": [
            "Naveena B"
          ],
          "lastName": [
            "Janakiram"
          ],
          "initials": [
            "NB"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        },
        {
          "fullName": [
            "Madka V"
          ],
          "firstName": [
            "Venkateshwar"
          ],
          "lastName": [
            "Madka"
          ],
          "initials": [
            "V"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        },
        {
          "fullName": [
            "Devarkonda V"
          ],
          "firstName": [
            "Vishal"
          ],
          "lastName": [
            "Devarkonda"
          ],
          "initials": [
            "V"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        },
        {
          "fullName": [
            "Brewer M"
          ],
          "firstName": [
            "Misty"
          ],
          "lastName": [
            "Brewer"
          ],
          "initials": [
            "M"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        },
        {
          "fullName": [
            "Biddick L"
          ],
          "firstName": [
            "Laura"
          ],
          "lastName": [
            "Biddick"
          ],
          "initials": [
            "L"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        },
        {
          "fullName": [
            "Lightfoot S"
          ],
          "firstName": [
            "Stan"
          ],
          "lastName": [
            "Lightfoot"
          ],
          "initials": [
            "S"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        },
        {
          "fullName": [
            "Steele VE"
          ],
          "firstName": [
            "Vernon E"
          ],
          "lastName": [
            "Steele"
          ],
          "initials": [
            "VE"
          ],
          "affiliation": [
            "Division of Cancer Prevention, Chemopreventive Agent Development Research Group, National Cancer Institute, Bethesda, MD, USA."
          ]
        },
        {
          "fullName": [
            "Mohammed A"
          ],
          "firstName": [
            "Altaf"
          ],
          "lastName": [
            "Mohammed"
          ],
          "initials": [
            "A"
          ],
          "affiliation": [
            "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "32"
      ],
      "volume": [
        "6"
      ],
      "journalIssueId": [
        "2335367"
      ],
      "dateOfPublication": [
        "2015 Oct"
      ],
      "monthOfPublication": [
        "10"
      ],
      "yearOfPublication": [
        "2015"
      ],
      "printPublicationDate": [
        "2015-10-01"
      ],
      "journal": [
        {
          "title": [
            "Oncotarget"
          ],
          "ISOAbbreviation": [
            "Oncotarget"
          ],
          "medlineAbbreviation": [
            "Oncotarget"
          ],
          "NLMid": [
            "101532965"
          ],
          "ESSN": [
            "1949-2553"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2015"
  ],
  "pageInfo": [
    "33290-33305"
  ],
  "abstractText": [
    "Cyclooxygenase-2 (COX-2), 5-Lipoxygenase (5-LOX), and epidermal growth factor receptor (EGRF) are over-expressed in human pancreatic ductal adenocarcinoma (PDAC). Using next-generation sequencing (NGS) analysis, we show significant increase in COX-2, 5-LOX, and EGFR expression during PDAC progression. Targeting complementary pathways will achieve better treatment efficacy than a single agent high-dose strategy that could increase risk of side effects and tumor resistance. To target COX-2, 5-LOX, and EGFR simultaneously, we tested effects of licofelone (dual 5-LOX-COX inhibitor), and gefitinib (EGFR inhibitor), individually and in combination, on pancreatic intraepithelial neoplasms (PanINs) and their progression to PDAC using genetically engineered mice. Individually, licofelone (L) and gefitinib (G) significantly inhibited incidence of PDAC in male (72% L, 90% G, p < 0.0001) and female (90% L, 85% G, p < 0.0001) mice. The combination drug treatment produced complete inhibition of PDAC in both genders. Pancreata of mice receiving combination treatment showed significantly fewer Dclk1-positive cancer stem-like cells, inhibition of COX-2, 5-LOX, PCNA, EGFR and Î²-catenin expression (p < 0.05-0.0002), increased p21 expression. Significant changes in tumor immune responses and desmoplastic reaction was observed by NGS analysis in combination treatment (p < 0.05). In summary, early simultaneous targeting of 5-LOX-COX- and EGFR pathways may provide additive inhibitory effects leading to complete suppression of PDAC."
  ],
  "affiliation": [
    "Center for Cancer Prevention and Drug Development, Department of Medicine, Hem-Onc Section, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Journal Article",
        "Research Support, Non-U.S. Gov't",
        "Research Support, N.I.H., Extramural"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "8P20GM103447"
          ],
          "agency": [
            "NIGMS NIH HHS"
          ],
          "acronym": [
            "GM"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "P20 GM103447"
          ],
          "agency": [
            "NIGMS NIH HHS"
          ],
          "acronym": [
            "GM"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "N01CN53300"
          ],
          "agency": [
            "NCI NIH HHS"
          ],
          "acronym": [
            "CA"
          ],
          "orderIn": [
            "0"
          ]
        },
        {
          "grantId": [
            "N01-CN-53300"
          ],
          "agency": [
            "NCI NIH HHS"
          ],
          "acronym": [
            "CN"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Animals"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mice, Inbred C57BL"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mice, Transgenic"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mice"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Carcinoma, Pancreatic Ductal"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pancreatic Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pyrroles"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Quinazolines"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Arachidonate 5-Lipoxygenase"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Receptor, Epidermal Growth Factor"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antineoplastic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Lipoxygenase Inhibitors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Signal Transduction"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Synergism"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cyclooxygenase 2"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cyclooxygenase 2 Inhibitors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "EGFR",
        "Inflammation",
        "Pancreatic cancer",
        "Chemoprevention"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antineoplastic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Pyrroles"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Quinazolines"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Lipoxygenase Inhibitors"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Arachidonate 5-Lipoxygenase"
          ],
          "registryNumber": [
            "EC 1.13.11.34"
          ]
        },
        {
          "name": [
            "Cyclooxygenase 2 Inhibitors"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Cyclooxygenase 2"
          ],
          "registryNumber": [
            "EC 1.14.99.1"
          ]
        },
        {
          "name": [
            "licofelone"
          ],
          "registryNumber": [
            "156897-06-2"
          ]
        },
        {
          "name": [
            "EGFR protein, mouse"
          ],
          "registryNumber": [
            "EC 2.7.10.1"
          ]
        },
        {
          "name": [
            "Receptor, Epidermal Growth Factor"
          ],
          "registryNumber": [
            "EC 2.7.10.1"
          ]
        },
        {
          "name": [
            "gefitinib"
          ],
          "registryNumber": [
            "S65743JHBS"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4741766?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4741766"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "http://dx.doi.org/10.18632/oncotarget.5396"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "0"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2016-08-29"
  ],
  "dateOfCreation": [
    "2015-10-30"
  ],
  "dateOfRevision": [
    "2016-12-03"
  ],
  "firstPublicationDate": [
    "2015-09-28"
  ]
}